What's more, the results of molecular docking also suggest that potential effective compounds have relatively stable binding energy with HSF1 and RELA, which provides a strong theoretical basis for us to further explore the role of HSF1 and RELA in A&P delaying or even reversing CKD induced by renal fibrosis. This evidence concerns the gene RELA and chronic kidney disease.